SCHEMBL208480

SCHEMBL208480

COC(=O)c1ccc(-c2cc(Cl)c(CC3CCN(C4CCCCC4)C3=O)c(Cl)c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.45
ALDH1A1 P00352 4/20 0.44
ATM Q13315 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
CHKA P35790 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
TSHR P16473 1/20 0.38
GLA P06280 1/20 0.36
OPRL1 P41146 1/20 0.36
MERTK Q12866 1/20 0.36
MAPK1 P28482 1/20 0.36
CHRM4 P08173 1/20 0.36
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL210504 0.90 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2CHKAMAPK1HPGD
SCHEMBL208947 0.90 ALDH1A1 (0.37) HSD11B1ALDH1A1ATMSMN1; SMN2NPSR1
SCHEMBL208948 0.90 ALDH1A1 (0.37) HSD11B1ALDH1A1ATMSMN1; SMN2NPSR1
SCHEMBL2999299 0.90 HSD11B1 (0.47) HSD11B1ALDH1A1ATMSMN1; SMN2NPSR1
SCHEMBL15204247 0.89 HSD11B1 (0.44) HSD11B1ALDH1A1ATMSMN1; SMN2NPSR1
SCHEMBL13266278 0.89 HSD11B1 (0.44) HSD11B1ALDH1A1ATMSMN1; SMN2NPSR1
SCHEMBL474903 0.89 CMA1 (0.35) HSD11B1ALDH1A1ATMSMN1; SMN2NPSR1
SCHEMBL210958 0.89 HRH3 (0.44) HSD11B1ALDH1A1SMN1; SMN2PDE4B
SCHEMBL209754 0.88 HSD11B1 (0.45) HSD11B1ALDH1A1NPSR1MAPT
SCHEMBL209306 0.88 HSD11B1 (0.51) HSD11B1PDE4BPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2016047-B1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11- BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2013-08-28 EP disclosed
US-8088776-B2 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2012-01-03 US disclosed
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD11B2 HSD11B1 1/4885ALDH1A1 88/4885ATM 3595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.